foxo4-dri longecity The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI alleviates age-related testosterone secretion
Description
Ex vivo cytotoxicity assay NIH/3T3 cells, transfected with FAP protein, were used as target cells
Trust Deeds can be recorded in first, second, or third lien position
*J Orthop Res.* 21(6):976-983
Description FOXO4-DRI is a synthetic D-retro-inverso peptide designed to selectively disrupt the FOXO4p53 protein-protein interaction
